KainosMed Rises 11.9% Amid Uptrend in COVID-19 (Diagnostics/Treatment/Vaccine Development) Theme

On the 22nd, the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme rose by 3.05% compared to the previous day, showing strength, while KainosMed, which is attracting attention as a related stock, surged by 11.9% compared to the previous day.

[Graph] Major stock price changes in the COVID-19 (diagnosis/treatment/vaccine development, etc.) theme



According to provisional data compiled at 10:10 AM, foreign investors sold 16,700 shares of KainosMed, resulting in a large net sell-off by foreign investors.

[Table] Net trading volume of foreign investors and institutions (unit: 10,000 shares)


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.